SIRUS PHARMACEUTICALS
SIRUS PHARMACEUTICALS
Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical
Status:
Active
Similar Organizations
Ayerst Pharmaceuticals
Ayerst Pharmaceuticals was added in 2013.
Cann Pharmaceuticals
Cann Pharmaceuticals
Fujisawa Healthcare
Subsidiaries of Fujisawa Pharmaceutical Co.
Fujisawa Research Institute of America
Subsidiaries of Fujisawa Pharmaceutical Co.
TiENLAND
Australian Pharmaceutical Health Products
Upjohn Pharmaceuticals
Upjohn Pharmaceuticals is a pharmaceutical manufacturing company.
Current Employees Featured
More informations about "Sirus Pharmaceuticals"
Sirus Pharmaceutical Ltd - Company Profile and News
Company profile page for Sirus Pharmaceutical Ltd including stock price, company news, executives, board members, and contact informationSee details»
Sirus 2025 Company Profile: Valuation, Investors, Acquisition
Sirus General Information Description. Operator of a pharmaceutical research company. The company focuses on drug development for the treatment of nerve injury and muscle spasm by …See details»
Sirus Pharmaceuticals Ltd - Drug pipelines, Patents, Clinical trials ...
Explore Sirus Pharmaceuticals Ltd with its drug pipeline, therapeutic area, technology platform, , Drug:SRSS-016, SGX-311, SGX-511, SRSA-360, SRSA-366. Products DataSee details»
Sirus Pharmaceuticals Ltd Company Profile, Financial and
DigitGaps report on Sirus Pharmaceuticals Ltd delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Sirus Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Sirus Pharmaceuticals . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Sirus Pharmaceuticals has …See details»
Sirius - Pharmaceuticals Pvt. Ltd.
Documentation and Regulatory compliance to International standards including USFDA and EDQM approvals.See details»
Sirus Pharmaceuticals - Crunchbase
Sirus Pharmaceuticals Ltd. Start Free Trial . Chrome ExtensionSee details»
Sirus Pharmaceuticals Ltd:Company Profile & Technical Research ...
Sirus Pharmaceuticals Ltd is a company that provides Nervous system, Medicine and more. Sirus Pharmaceuticals Ltd is headquartered in United Kingdom . Sirus Pharmaceuticals Ltd has a …See details»
Sirus Pharmaceuticals Limited - Party | RPX Insight
Sirus Pharmaceuticals Limited has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendant ... View as Organization Sirus …See details»
Arakis Acquires Sirus, Gains Access To Sublingual Platform
Mar 31, 2004 LONDON - Arakis Ltd. embarked on its third funding round to raise £25 million (US$45.5 million) or more, and acquired privately held Sirus Pharmaceuticals Ltd. in an all …See details»
SGX-311 - Drug Targets, Indications, Patents - Synapse
SGX-311, Initially developed by Sirus Pharmaceuticals Ltd, Now, its global highest R&D status is Discontinued, Therapeutic Areas: Nervous System Diseases. ... Originator Organization. Sirus …See details»
Sirius Pharmaceuticals Private Limited | Company Details
Dec 25, 2024 Sirius Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 1991 and has a history of 33 years …See details»
Sirus Pharmaceuticals Ltd:Acquisition,Acquisition Analysis
Discovery Company profile page for Sirus Pharmaceuticals Ltd including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Sirius - 2025 Company Profile & Competitors - Tracxn
Apr 7, 2025 Sirius - Company offers a wide range of services including API & FDF development and manufacturing. Sirius has 752 competitors. ... Sirius Pharmaceuticals Private Limited. Oct …See details»
Sirus and GSK extend collaboration on neuropathic pain
UK company Sirus Pharmaceuticals has extended an existing research collaboration with GlaxoSmithKline based upon promising results in models of neuropathic pain. Sirus is …See details»
SGX-511 - Drug Targets, Indications, Patents - Synapse - Patsnap
SGX-511, Initially developed by Sirus Pharmaceuticals Ltd, Now, its global highest R&D status is Discontinued, Therapeutic Areas: Nervous System Diseases. ... Originator Organization. Sirus …See details»
Anonymous Global Pharmaceutical - Sirus
Sirus supplied a ‘Siemens Desigo Insight’ building management system (53 PXC100-E.D BMS controllers) which consisted of: 51 Non-Qualified Control Panels, 3,522 I/O, 8 Thin Clients; 1 …See details»
Sirus Pharmaceuticals Ltd - PlainSite
Sirus Pharmaceuticals Ltd litigation, intellectual property, attorneys, sec filings, and other public records. Sirus Pharmaceuticals Ltd United States C Corporation. No tags have been applied …See details»
TRS 1060 - World Health Organization (WHO)
1 day ago This guideline is applicable to all manufacturers and packers of excipients, active pharmaceutical ingredients, processing aids and finished pharmaceutical products. WHO …See details»
SGX-311 - Drug Targets, Indications, Patents - Synapse
SGX-311, Initially developed by Sirus Pharmaceuticals Ltd, Now, its global highest R&D status is Discontinued, Therapeutic Areas: Nervous System Diseases. Biomedical products. Data. …See details»